Core Viewpoint - A class action has been filed against Bath & Body Works, Inc. for allegedly misleading investors regarding its business strategy and financial performance during a specified period [1][2]. Group 1: Allegations and Financial Performance - The complaint alleges that Bath & Body Works did not disclose that its strategy of pursuing "adjacencies, collaborations and promotions" was failing to grow its customer base and was not delivering the expected growth in net sales [2]. - The company reported disappointing third quarter 2025 results, with a revenue decline of 1% year over year, missing the guidance of 1-3% growth, and a net income drop of 26% to $77 million [3]. - Following the release of these results, Bath & Body Works cut its full-year guidance for net sales and reduced expected earnings per diluted share from $3.28 to "at least $2.83" [3]. Group 2: Strategic Changes - In an investor presentation, Bath & Body Works acknowledged that its previous strategy had not grown its total customer base and admitted to an over-reliance on promotions to drive growth [3]. - The company announced plans to exit certain adjacencies and refocus on its core categories to improve performance [3]. Group 3: Market Reaction - On November 20, 2025, following the disappointing financial results and strategic announcements, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share [4].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 13, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was effective in driving topline growth through category adjacencies [5]. Group 3: Stock Performance and Financial Results - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock price drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 financial results on November 20, 2025, which revealed that the strategy of pursuing adjacencies had not grown the customer base, the stock price fell by $5.22 per share, or 24.8% [7].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit against Bath & Body Works, Inc. for allegedly misleading investors regarding its business operations during the specified class period from June 4, 2024, to November 19, 2025 [1][2]. Allegations - The lawsuit claims that Bath & Body Works made materially false and misleading statements about its growth strategy, which included "adjacencies, collaborations, and promotions," failing to grow its customer base or achieve the projected net sales growth [3]. - It is alleged that as the company's strategy faltered, it relied on brand collaborations to mask weak financial results, leading to a failure to meet previously issued financial guidance [3]. - The lawsuit asserts that the positive statements made by the defendants regarding Bath & Body Works' business and prospects were materially misleading and lacked a reasonable basis, resulting in investor damages when the truth was revealed [3]. Next Steps - Shareholders interested in participating in the class action must file their motions to serve as lead plaintiff by March 16, 2026. A lead plaintiff represents the class in directing the litigation [4]. - Shareholders can choose to remain absent from the case while still being eligible for recovery [4]. About Rosen Law Firm - Rosen Law Firm is recognized for its commitment to shareholder rights litigation, having recovered over $1 billion for shareholders since its inception [6].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. for alleged securities fraud, impacting shareholders who acquired the company's securities between June 4, 2024, and November 19, 2025 [1][2]. Financial Performance - On August 28, 2025, Bath & Body Works reported Q2 2025 earnings per diluted share of $0.30, a decline of 55.8% year over year, and net income of $64 million, down 57.9% year over year [3]. - The company cut its full-year guidance for earnings per diluted share by $0.03, adjusting it to a range of $3.28 to $3.53 [3]. - Following this announcement, the stock price fell by $2.18, or 6.9%, closing at $29.36 per share [4]. Subsequent Developments - On November 20, 2025, Bath & Body Works released Q3 2025 results, reporting a 1% decline in revenue year over year and a 26% drop in net income to $77 million [5]. - The company revised its full-year guidance for net sales from a previously positive range of 1.5%-2.7% to a negative "high single digits" and cut expected earnings per diluted share to "at least $2.83" [5]. - The stock price subsequently fell by $5.22, or 24.8%, closing at $15.82 per share [6]. Allegations in the Lawsuit - The lawsuit alleges that the company made materially false and misleading statements and failed to disclose adverse facts about its business and operations [7]. - Specific allegations include the failure to disclose that the strategy of pursuing "adjacencies, collaborations, and promotions" was not effective in growing the customer base or delivering expected sales growth [7][8]. - It is claimed that the company relied on brand collaborations to mask weak financial results and was unlikely to meet its previously issued financial guidance [8].

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (NYSE: BBWI) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Bath & Body securities between June 4, 2024 and November 19, 2025, bo ...

LOS ANGELES--(BUSINESS WIRE)--Bath & Body Works, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BBWI. ...

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops due to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - Investors have until March 13, 2026, to request to be appointed to lead the case, which is based on claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2][3]. - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was driving topline growth through these new categories [5]. Group 3: Stock Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, leading to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 per share [6]. - Following the release of Q3 2025 financial results on November 20, 2025, which included a further reduction in full-year guidance and acknowledgment that the strategy had not grown the customer base, the stock fell by $5.22, or 24.8%, from $21.04 to $15.82 per share [7].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 13, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was driving topline growth through category adjacencies [5]. Group 3: Stock Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 results on November 20, 2025, which revealed that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22 per share, or 24.8% [7].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. for alleged violations of securities laws, claiming the company made false and misleading statements that negatively impacted investors [1][4]. Group 1: Lawsuit Details - The lawsuit pertains to violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, are encouraged to participate in the lawsuit [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Allegations Against the Company - The complaint alleges that Bath & Body Works made false and misleading statements regarding its business strategy, which included seeking "adjacencies, collaborations and promotions" that failed to grow its customer base and net sales [4]. - The company reportedly relied on brand collaborations to "carry quarters" despite experiencing weak financial results, leading to misleading public statements throughout the class period [4]. - Investors suffered damages when the truth about the company's performance was revealed [4].

Group 1 - A shareholder class action lawsuit has been filed against Bath & Body Works, alleging false and misleading statements regarding the company's growth strategy and financial performance [1] - The lawsuit claims that Bath & Body Works's strategy did not effectively grow the customer base or deliver the expected growth in net sales [1] - It is alleged that the company relied on brand collaborations to mask weak underlying financial results, leading to doubts about meeting previously issued financial guidance [1] Group 2 - Investors who purchased Bath & Body Works shares between June 4, 2024, and November 19, 2025, and suffered significant losses are encouraged to seek legal advice [2] - Holzer & Holzer, LLC is a law firm specializing in shareholder class action and derivative litigation, with a history of recovering substantial amounts for shareholders affected by corporate misconduct [3]